Citation Impact
Citing Papers
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Exosomes and other extracellular vesicles in host–pathogen interactions
2014
Microbiota in health and diseases
2022 Standout
Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents
2011
Engineering precision nanoparticles for drug delivery
2020 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
2016
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018 StandoutNobel
Bioneedles as alternative delivery system for hepatitis B vaccine
2010
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
The molecular machinery of regulated cell death
2019 Standout
Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation
2016
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Biomedical applications of biodegradable polymers
2011 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses
2017
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Designing antimicrobial peptides: form follows function
2011 Standout
Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections
2013
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Microneedles for drug and vaccine delivery
2012 Standout
Outer Membrane Vesicles (OMVs) Produced by Gram‐Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application
2021
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria
2022
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
2017 Standout
Cell Membrane Coating Nanotechnology
2018
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Recent Advances in Drug Delivery Systems
2011
The expanding role of immunopharmacology: IUPHAR Review 16
2015
A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A Streptococcus
2016 StandoutNobel
Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation
2010
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles
2019
Vaccines: the Fourth Century
2009
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Synthetic Nanoparticles for Vaccines and Immunotherapy
2015
Works of Reinaldo Acevedo being referenced
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice
2009
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice
2008
Optimizing efficacy of mucosal vaccines
2012
Strategy for determination of an efficient Cochleate particle size
2005
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine
2005
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses
2009
Bacterial Outer Membrane Vesicles and Vaccine Applications
2014
Novel adjuvant based on a proteoliposome‐derived cochleate structure containing native lipopolysaccharide as a pathogen‐associated molecular pattern
2004
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
2008